Nicotinamide Mononucleotide

DB03227InvestigationalSmall molecule

3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN. [PubChem].

Chemical structure of Nicotinamide Mononucleotide
Formula / weight
C11H16N2O8P · 335.2271 g/mol (avg)

Resolves to

Compound
UNII2KG6QX4W0VChEBI50383PubChem6093202
Clinical / RWD
RxNorm2262276
Structure
InChIKeyDAYLJWODMCOQEW-WYOJIJJFSA-OSMILESNC(=O)C1=CC=C[N+](=C1)[C@@H]1O[C@@H](COP(O)(O)=O)[C@H](O)[C@H]1O
Targets
Q10588BST1Q9HAN9NMNAT1Q96T66NMNAT3Q837V6ligA

What you can answer from here — as of August 31, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
18Marketed productsAcross 1 country and 8 labellers
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nicotinamide Mononucleotide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In